TWST · Twist Bioscience Corp · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $183.28 to $184.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
501 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $178.1 to $179 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
330 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $175 to $175.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
2,485 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $182.25 to $183.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
16 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $177.05 to $177.4 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
164 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $184.33 to $184.96 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
83 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $181.23 to $181.61 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
21 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $180.23 to $181.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
515 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $176 to $176.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
945 |
| 2026-09-24 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $179.23 to $180.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
143 |
| 2026-09-21 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
348 |
| 2026-09-21 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
294 |
| 2026-09-21 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
1,687 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $150.77 to 151.77 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
2,440 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $152.87 to $153.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
3,399 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $163.03 to $163.6 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
869 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $158.99 to $159.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
23,884 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $153.88 to $154.84 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
4,175 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $160.00 to $160.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
14,493 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $161.00 to $161.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
11,169 |
| 2026-09-17 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. |
Common Stock
|
133,269 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $151.78 to $152.71 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
6,644 |
| 2026-09-17 | Leproust Emily M. |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option is immediately exercisable. 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vested and became exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
133,269 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $157.97 to $158.96 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
232,173 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $155.92 to $156.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
9,097 |
| 2026-09-17 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. |
Common Stock
|
75,439 |
| 2026-09-17 | Leproust Emily M. |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
75,439 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $156.96 to $157.96 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
32,260 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $162.02 to $163 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
2,565 |
| 2026-09-17 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $154.9 to $155.9 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
13,378 |
| 2026-09-08 | WERNER ROBERT F. |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
238 |
| 2026-09-08 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
412 |
| 2026-09-08 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
2,302 |
| 2026-09-08 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
907 |
| 2026-08-25 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $152.33 to $153.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
6,412 |
| 2026-08-25 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $153.34 to $154.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
9,181 |
| 2026-08-25 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $154.34 to $154.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
1,093 |
| 2026-08-25 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $150.00 to $150.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
12,648 |
| 2026-08-25 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $151.00 to $151.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
12,236 |
| 2026-08-24 | WERNER ROBERT F. |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
854 |
| 2026-08-21 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
1,598 |
| 2026-08-21 | Finn Patrick John |
President and COO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Common Stock
|
4,046 |
| 2026-08-21 | WERNER ROBERT F. |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
669 |
| 2026-08-21 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
6,639 |
| 2026-08-21 | Laponis Adam |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Common Stock
|
1,965 |
| 2026-08-21 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
1,360 |
| 2026-08-19 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026. |
Common Stock
|
14,205 |
| 2026-08-18 | Finn Patrick John |
President and COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $122.00 to $122.815 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
2,000 |
| 2026-08-18 | Finn Patrick John |
President and COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $117.37to $118.19 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
8,868 |
| 2026-08-18 | Finn Patrick John |
President and COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026. Represents the weighted average sales price per share. The shares sold at prices ranging from $120.585 to $121.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
6,296 |